Clinical trial
Safety and Efficacy Study of rEV131 in Allergic Rhinitis
NCT00247520 · Evolutec Group, Industry · Unknown status
Key facts
| NCT number | NCT00247520 |
|---|---|
| Title | Safety and Efficacy Study of rEV131 in Allergic Rhinitis |
| Official title | Two Center Evaluation of the Safety and Efficacy of Topical Nasal rEV131 Versus rEV131 Vehicle (Placebo)in the Prevention of the Signs and Symptoms of Allergic Rhinitis Induced by Nasal Allergen Challenge |
| Lead sponsor | Evolutec Group, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hay Fever |
| Intervention type | Drug |
| Interventions | topical nasal rEV131 |
| Enrollment | 112 |
| Start date | May 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Nov 2, 2005 |
| Last update posted | Nov 2, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: